Thursday, May 28, 2015 8:40:57 AM
ndr.de visit 28/04/2015
Ulrich Neumann
Herpes on the lips to know many people. It develop painful small vesicles. But the herpes virus can be really dangerous and trigger a so-called herpes virus sepsis in a weakened immune system. Sepsis (blood poisoning) is a complex inflammatory response of the body to an infection with bacteria, viruses or fungi. Normally, the immune system helps reducing such infections. Make it not, the pathogens can spread through the bloodstream throughout the body.
Failure of the immune system
The sepsis is thus quasi based on a failure of the immune system. In an excessive reaction large amounts of messenger substances are released (including interleukins, interferons, prostaglandins, leukotrienes) that maintains keep the inflammatory response throughout the body, without being thereby availed of combating pathogens. As a result, metabolic processes become confused and the bodies will eventually no longer be supplied with sufficient oxygen. Cardiovascular failure, kidney failure, bleeding disorders and respiratory failure may result.
As part of an intensive medical therapy, the organ functions, for example, by using circulation supportive medicines, artificial respiration or the use of renal replacement therapy (dialysis) can be temporarily supported or replaced. Nevertheless, die 30 to 50 percent of sufferers. Sepsis is a race against time. With every hour that passes without a treatment is started, the prognosis worsens dramatically.
Blood purification removes inflammatory neurotransmitters
There is new scientific evidence that can be influenced by the removal of pro-inflammatory messenger substances from the blood, the overreaction of the immune system and the clinical condition of septic patients with organ failure low. Since the year 2011 is to a particular device: a so-called Zytokinabsorber (Cytosorb). Similar to a dialysis thus may be removed as part of a blood purification from the blood substances (especially cytokines) that initiate or maintain inflammation.
So far, this treatment is only available at special centers in Germany. However, the experience has been entirely positive: The cardiovascular function of the affected stabilize rapidly. Already within 12 to 24 hours after initiation of therapy decrease the cytokine levels in the blood strongly.
However, all questions about this therapy are not fully understood. Perhaps the hemodialysis affects not only the cytokine concentration in the blood, but also the concentration of other vital messengers and essential medicines and nutrients. Can be used until the Zytokinabsorber default, yet studies have to be carried out.
Dr. Carlos Fritzsche
Specialist Internal Medicine and Infectious Diseases
Consultant at the Department of Infectious Diseases and Tropical Medicine
Department of Internal Medicine, University Hospital Rostock
Ernst-Heydemann-Straße 6
18057 Rostock
Prof. Dr. Steffen Mitzner
head of the Section of Nephrology
Department of Internal Medicine, University Hospital Rostock
Ernst-Heydemann-Straße 6
18057 Rostock
Tel. (0381) 494 77 31
Fax: (0381) 494 77 32
E-mail: steffen.mitzner@med.uni-rostock.de
Prof. Dr. Tung Yu Tsui, FACS
Section Head Oncological Surgery and Transplantation
Department General-, Thoracic, Vascular and Transplant Surgery
Department of Surgery
University Hospital Rostock
Schillingallee 35, 18057 Rostock
Tel. (0381) 494 60 08
Fax: (0381) 494 60 02
Recent CTSO News
- CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference • GlobeNewswire Inc. • 08/27/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/20/2024 08:51:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 10:58:42 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 10:57:45 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/16/2024 09:28:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 09:12:04 PM
- CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 08/16/2024 08:05:00 PM
- CytoSorbents Reports Second Quarter 2024 Financial and Operational Results • GlobeNewswire Inc. • 08/13/2024 08:19:55 PM
- CytoSorbents Appoints Peter J. Mariani Chief Financial Officer • GlobeNewswire Inc. • 08/13/2024 08:18:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:04:32 PM
- CytoSorbents to Report Second Quarter 2024 Operating and Financial Results • GlobeNewswire Inc. • 08/07/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:12:56 PM
- CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 08/01/2024 11:00:00 AM
- CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website • GlobeNewswire Inc. • 07/29/2024 12:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/26/2024 09:14:03 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/26/2024 09:11:21 PM
- CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress • GlobeNewswire Inc. • 07/17/2024 11:00:00 AM
- CytoSorbents Secures $20 Million Credit Facility • GlobeNewswire Inc. • 07/02/2024 11:00:00 AM
- CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan • GlobeNewswire Inc. • 06/24/2024 11:00:00 AM
- CytoSorbents Announces the Launch and Immediate Availability of the PuriFi™ Blood Pump in the European Union • GlobeNewswire Inc. • 06/13/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 08:31:20 PM
- CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting • GlobeNewswire Inc. • 06/05/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 08:35:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 09:23:00 PM
- CytoSorbents Reports First Quarter 2024 Results • GlobeNewswire Inc. • 05/09/2024 08:17:23 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM